Melbourne hospital operator Western Health is facing a potential class action by junior doctors alleging they have been denied overtime pay, the third underpayments class action to be filed by doctors in Victoria.
The former chief financial officer of delisted Traditional Therapy Clinics has been sentenced to one year and ten months in prison after pleading guilty to market manipulation charges relating to transactions intended to create an artificial share price for the traditional therapy clinic company.
The lead applicant in a class action against Bayer over its allegedly defective Essure contraceptive devices has won court approval to drop her consumer law claims against the German drug maker, with a judge agreeing that the plaintiff’s defect and negligence claims had a better chance of succeeding.
A former CEO of a global pharmaceutical company has lost his appeal of a ruling throwing out a lawsuit he brought against his former employer after he was terminated in the wake of accusations that he harassed staff and using a syringe to stab multiple employees.
The Australian Competition and Consumer Commission has dropped a consumer case accusing NIB Health Funds of failing to alert customers to coverage changes in their policies, less than a month before trial was set to kick off in the long-running case.
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant’s patents for its blockbuster MS drug Gilenya.
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF — including pre-implantation genetic testing — are the targets of a new class action investigation.
A judge weighing a $38.4 million settlement in a shareholder class action against aged care provider Estia Health has been told that two NSW Court of Appeal judgments barring class closure were âplainly wrongâ, but in deciding whether to lock group members out of the settlement the judge says he wonât need to grapple with the landmark rulings.
Staff members who worked for two Melbourne aged care providers will be removed as group members in class actions accusing the homes of negligently handling the coronavirus pandemic.
The companies behind the top selling Abilify medication have lost their latest bid for documents from the Commonwealth in a multimillion dollar dispute over the delayed listing of generic versions of their drug, with a judge saying the material could be only “of the most marginal relevance”.